Northwest Biotherapeutics (NWBO) EBT Margin Growth (5y) (2015 - 2026)
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) EBT Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Northwest Biotherapeutics | 278.23 Mn | 277.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 151,424.00 |
| Mar 31, 2026 | 611,235.00 |
| Dec 31, 2025 | 250,309.00 |
| Sep 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | 41.71 Mn |
| Mar 31, 2025 | -355,961.00 |
| Dec 31, 2024 | -825,585.00 |
| Sep 30, 2024 | -349,603.00 |
| Jun 30, 2024 | -247,612.00 |
| Mar 31, 2024 | -356,430.00 |
| Dec 31, 2023 | -471,084.00 |
| Sep 30, 2023 | -140,701.00 |
| Jun 30, 2023 | 110,686.00 |
| Mar 31, 2023 | 760,708.00 |
| Dec 31, 2022 | 5.87 Mn |
| Sep 30, 2022 | 203,987.00 |
| Jun 30, 2022 | 888,220.00 |
| Mar 31, 2022 | 1.57 Mn |
| Sep 30, 2021 | 1.32 Mn |
| Jun 30, 2021 | 685,668.00 |